ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
antibody
|
272 |
104K |
4 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
272
|
104K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
18 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
22 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
4 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
20 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
15 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
19 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
19
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
antibody
|
10K |
3.0M |
4 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
10K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
21 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
18 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
19 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
19
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
17 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
12 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
11 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
17 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
antibody
|
10K |
3.0M |
20 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
10K
|
3.0M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
20 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
15 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
15 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
15 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
22 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
24 |
26/01/24 |
26/01/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
16 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
16 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
20 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
antibody
|
380 |
130K |
6 |
21/01/24 |
21/01/24 |
ASX - By Stock
|
380
|
130K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
9 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
antibody
|
10K |
3.0M |
1 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
23 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
10 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
32 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
32
|
|
ASX - By Stock
|
MSB |
Re:
MSB is back on its Fast and Furious SUCCESS Track - We Need these Types of SUCCESS!
|
|
antibody
|
18 |
5.2K |
0 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
18
|
5.2K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
antibody
|
10K |
3.0M |
8 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
10K
|
3.0M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
antibody
|
10K |
3.0M |
3 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
ADO |
Re:
Ann: Commercialisation Milestone
|
|
antibody
|
341 |
112K |
1 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
341
|
112K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
antibody
|
10K |
3.0M |
13 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
10K
|
3.0M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
antibody
|
512 |
129K |
5 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
512
|
129K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
antibody
|
512 |
129K |
6 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
512
|
129K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
antibody
|
512 |
129K |
18 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
512
|
129K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Taken up the entitlement?
|
|
antibody
|
544 |
135K |
5 |
25/12/23 |
25/12/23 |
ASX - By Stock
|
544
|
135K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Entitlement Offer and Placement Investor Presentation
|
|
antibody
|
48 |
15K |
13 |
23/12/23 |
23/12/23 |
ASX - By Stock
|
48
|
15K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
23 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
19 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
19
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
15 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
37 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
37
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
25 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
25
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
22 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
17 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
23 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
antibody
|
5.4K |
2.7M |
16 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
16
|
|